Pediatric Brain Tumors: Narrating Suffering and End-of-Life Decisionmaking.


Journal

Cambridge quarterly of healthcare ethics : CQ : the international journal of healthcare ethics committees
ISSN: 1469-2147
Titre abrégé: Camb Q Healthc Ethics
Pays: United States
ID NLM: 9208482

Informations de publication

Date de publication:
07 2020
Historique:
entrez: 3 6 2020
pubmed: 3 6 2020
medline: 26 11 2021
Statut: ppublish

Résumé

When talking about decisionmaking for children with a life-threatening condition, the death of children with brain tumors deserves special attention. The last days of the lives of these children can be particularly harsh for bystanders, and raise questions about the suffering of these children themselves. In the Netherlands, these children are part of the group for whom a wide range of end-of-life decisions are discussed, and questions raised. What does the end-of-life for these children look like, and what motivates physicians and parents to make decisions that may affect the life and death of these children? This article highlights the story of the parents of the sisters Roos and Noor. When both their daughters were diagnosed with a hereditary brain tumor, they had to make similar decisions twice. Their story sheds light on the suffering of children in the terminal phase, and how this suffering may motivate parents and physicians to make decisions that influence the end of life of these children's lives.We argue that complete knowledge about suffering in the terminal phase of children with brain tumors is impossible. However, by collecting experiences like those of Roos and Noor, we can move toward an experienced-based understanding and better guide parents and physicians through these hardest of decisions.

Identifiants

pubmed: 32484136
doi: 10.1017/S0963180120000055
pii: S0963180120000055
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

338-345

Commentaires et corrections

Type : CommentIn

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH